nodes	percent_of_prediction	percent_of_DWPC	metapath
Clopidogrel—CES1—Mycophenolate mofetil—psoriasis	0.13	0.177	CbGbCtD
Clopidogrel—CYP2C8—Tazarotene—psoriasis	0.051	0.0696	CbGbCtD
Clopidogrel—CYP3A5—Beclomethasone—psoriasis	0.0493	0.0673	CbGbCtD
Clopidogrel—CYP1A2—Clobetasol propionate—psoriasis	0.0484	0.0661	CbGbCtD
Clopidogrel—CYP2B6—Cholecalciferol—psoriasis	0.0287	0.0392	CbGbCtD
Clopidogrel—CYP1A2—Methoxsalen—psoriasis	0.0254	0.0347	CbGbCtD
Clopidogrel—CYP2C8—Cholecalciferol—psoriasis	0.0218	0.0297	CbGbCtD
Clopidogrel—CYP3A5—Mycophenolate mofetil—psoriasis	0.0196	0.0268	CbGbCtD
Clopidogrel—CYP2C8—Mycophenolate mofetil—psoriasis	0.0189	0.0258	CbGbCtD
Clopidogrel—CYP2C19—Cholecalciferol—psoriasis	0.0182	0.0249	CbGbCtD
Clopidogrel—CYP3A4—Calcitriol—psoriasis	0.0171	0.0234	CbGbCtD
Clopidogrel—CYP3A5—Hydrocortisone—psoriasis	0.0157	0.0215	CbGbCtD
Clopidogrel—CYP2C9—Cholecalciferol—psoriasis	0.0152	0.0207	CbGbCtD
Clopidogrel—CYP2C8—Hydrocortisone—psoriasis	0.0151	0.0207	CbGbCtD
Clopidogrel—CYP3A5—Cyclosporine—psoriasis	0.0149	0.0203	CbGbCtD
Clopidogrel—CYP2C8—Cyclosporine—psoriasis	0.0143	0.0195	CbGbCtD
Clopidogrel—CYP3A4—Methoxsalen—psoriasis	0.0133	0.0182	CbGbCtD
Clopidogrel—ABCB1—Mycophenolate mofetil—psoriasis	0.0128	0.0174	CbGbCtD
Clopidogrel—CYP2C19—Prednisone—psoriasis	0.0126	0.0173	CbGbCtD
Clopidogrel—CYP2B6—Dexamethasone—psoriasis	0.0124	0.017	CbGbCtD
Clopidogrel—CYP2C19—Cyclosporine—psoriasis	0.012	0.0164	CbGbCtD
Clopidogrel—ABCB1—Betamethasone—psoriasis	0.011	0.015	CbGbCtD
Clopidogrel—ABCB1—Prednisolone—psoriasis	0.0108	0.0148	CbGbCtD
Clopidogrel—ABCB1—Hydrocortisone—psoriasis	0.0102	0.014	CbGbCtD
Clopidogrel—ABCB1—Prednisone—psoriasis	0.0102	0.0139	CbGbCtD
Clopidogrel—CYP2C9—Cyclosporine—psoriasis	0.00997	0.0136	CbGbCtD
Clopidogrel—CYP3A5—Dexamethasone—psoriasis	0.00979	0.0134	CbGbCtD
Clopidogrel—ABCB1—Cyclosporine—psoriasis	0.00967	0.0132	CbGbCtD
Clopidogrel—CYP2C8—Dexamethasone—psoriasis	0.00941	0.0129	CbGbCtD
Clopidogrel—CYP3A4—Cholecalciferol—psoriasis	0.00882	0.012	CbGbCtD
Clopidogrel—CYP2C19—Dexamethasone—psoriasis	0.0079	0.0108	CbGbCtD
Clopidogrel—CYP3A4—Triamcinolone—psoriasis	0.00765	0.0104	CbGbCtD
Clopidogrel—CYP3A4—Mycophenolate mofetil—psoriasis	0.00765	0.0104	CbGbCtD
Clopidogrel—CYP2C9—Dexamethasone—psoriasis	0.00656	0.00896	CbGbCtD
Clopidogrel—CYP3A4—Betamethasone—psoriasis	0.00656	0.00896	CbGbCtD
Clopidogrel—CYP3A4—Prednisolone—psoriasis	0.00647	0.00884	CbGbCtD
Clopidogrel—ABCB1—Dexamethasone—psoriasis	0.00637	0.0087	CbGbCtD
Clopidogrel—CYP3A4—Hydrocortisone—psoriasis	0.00614	0.00838	CbGbCtD
Clopidogrel—CYP3A4—Prednisone—psoriasis	0.00611	0.00835	CbGbCtD
Clopidogrel—CYP3A4—Cyclosporine—psoriasis	0.0058	0.00792	CbGbCtD
Clopidogrel—ABCB1—Methotrexate—psoriasis	0.00512	0.00699	CbGbCtD
Clopidogrel—CYP3A4—Dexamethasone—psoriasis	0.00382	0.00521	CbGbCtD
Clopidogrel—CYP2B6—CYP2E1 reactions—CYP2S1—psoriasis	0.0017	0.0562	CbGpPWpGaD
Clopidogrel—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	0.00144	0.0475	CbGpPWpGaD
Clopidogrel—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00129	0.0424	CbGpPWpGaD
Clopidogrel—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00117	0.0387	CbGpPWpGaD
Clopidogrel—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.00106	0.0348	CbGpPWpGaD
Clopidogrel—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.00103	0.034	CbGpPWpGaD
Clopidogrel—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.000894	0.0295	CbGpPWpGaD
Clopidogrel—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.000798	0.0263	CbGpPWpGaD
Clopidogrel—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000728	0.024	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—IL22—psoriasis	0.000625	0.0206	CbGpPWpGaD
Clopidogrel—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000622	0.0205	CbGpPWpGaD
Clopidogrel—P2RY12—G alpha (i) signalling events—HCAR2—psoriasis	0.000552	0.0182	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—SERPINB8—psoriasis	0.000493	0.0163	CbGpPWpGaD
Clopidogrel—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.00048	0.0158	CbGpPWpGaD
Clopidogrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.000439	0.0145	CbGpPWpGaD
Clopidogrel—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000439	0.0145	CbGpPWpGaD
Clopidogrel—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000433	0.0143	CbGpPWpGaD
Clopidogrel—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000429	0.0141	CbGpPWpGaD
Clopidogrel—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000423	0.0139	CbGpPWpGaD
Clopidogrel—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000371	0.0122	CbGpPWpGaD
Clopidogrel—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000366	0.0121	CbGpPWpGaD
Clopidogrel—CES1—NRF2 pathway—TGFA—psoriasis	0.000362	0.0119	CbGpPWpGaD
Clopidogrel—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000356	0.0117	CbGpPWpGaD
Clopidogrel—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000348	0.0115	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR ligand binding—HCAR2—psoriasis	0.000334	0.011	CbGpPWpGaD
Clopidogrel—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000331	0.0109	CbGpPWpGaD
Clopidogrel—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000327	0.0108	CbGpPWpGaD
Clopidogrel—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000302	0.00996	CbGpPWpGaD
Clopidogrel—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000301	0.00992	CbGpPWpGaD
Clopidogrel—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000298	0.00983	CbGpPWpGaD
Clopidogrel—P2RY12—G alpha (i) signalling events—CCL20—psoriasis	0.000287	0.00945	CbGpPWpGaD
Clopidogrel—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000269	0.00886	CbGpPWpGaD
Clopidogrel—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000259	0.00853	CbGpPWpGaD
Clopidogrel—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000258	0.00851	CbGpPWpGaD
Clopidogrel—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000255	0.0084	CbGpPWpGaD
Clopidogrel—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000245	0.00807	CbGpPWpGaD
Clopidogrel—CES1—Fluoropyrimidine Activity—TP53—psoriasis	0.000232	0.00765	CbGpPWpGaD
Clopidogrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.000228	0.00751	CbGpPWpGaD
Clopidogrel—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000209	0.0069	CbGpPWpGaD
Clopidogrel—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000201	0.00664	CbGpPWpGaD
Clopidogrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000199	0.00657	CbGpPWpGaD
Clopidogrel—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000197	0.00648	CbGpPWpGaD
Clopidogrel—CYP2B6—Biological oxidations—CYP2S1—psoriasis	0.000189	0.00623	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—HCAR2—psoriasis	0.000189	0.00622	CbGpPWpGaD
Clopidogrel—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	0.000186	0.00614	CbGpPWpGaD
Clopidogrel—CYP3A5—Biological oxidations—CYP2S1—psoriasis	0.000185	0.00608	CbGpPWpGaD
Clopidogrel—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	0.000182	0.006	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR ligand binding—CCL20—psoriasis	0.000174	0.00572	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—HCAR2—psoriasis	0.000171	0.00565	CbGpPWpGaD
Clopidogrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000162	0.00533	CbGpPWpGaD
Clopidogrel—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.00016	0.00527	CbGpPWpGaD
Clopidogrel—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000159	0.00525	CbGpPWpGaD
Clopidogrel—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000158	0.0052	CbGpPWpGaD
Clopidogrel—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000153	0.00506	CbGpPWpGaD
Clopidogrel—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000149	0.0049	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—ITGAL—psoriasis	0.000143	0.00472	CbGpPWpGaD
Clopidogrel—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000143	0.0047	CbGpPWpGaD
Clopidogrel—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000141	0.00464	CbGpPWpGaD
Clopidogrel—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00014	0.00463	CbGpPWpGaD
Clopidogrel—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000139	0.00458	CbGpPWpGaD
Clopidogrel—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000138	0.00456	CbGpPWpGaD
Clopidogrel—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.00013	0.00429	CbGpPWpGaD
Clopidogrel—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000128	0.00423	CbGpPWpGaD
Clopidogrel—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.000127	0.00417	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000124	0.00408	CbGpPWpGaD
Clopidogrel—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000119	0.00391	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000118	0.0039	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—IL13—psoriasis	0.000118	0.00388	CbGpPWpGaD
Clopidogrel—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000111	0.00367	CbGpPWpGaD
Clopidogrel—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.00011	0.00362	CbGpPWpGaD
Clopidogrel—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000109	0.00361	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—IL17A—psoriasis	0.000108	0.00357	CbGpPWpGaD
Clopidogrel—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000108	0.00355	CbGpPWpGaD
Clopidogrel—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000104	0.00341	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—HCAR2—psoriasis	0.000101	0.00334	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—IL12B—psoriasis	0.000101	0.00332	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—HLA-E—psoriasis	9.83e-05	0.00324	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—CCL20—psoriasis	9.81e-05	0.00323	CbGpPWpGaD
Clopidogrel—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.68e-05	0.00319	CbGpPWpGaD
Clopidogrel—CYP1A2—Tryptophan metabolism—CAT—psoriasis	9.59e-05	0.00316	CbGpPWpGaD
Clopidogrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	9.15e-05	0.00302	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—CCL20—psoriasis	8.9e-05	0.00294	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TAGAP—psoriasis	8.78e-05	0.00289	CbGpPWpGaD
Clopidogrel—CYP3A4—Biological oxidations—CYP2S1—psoriasis	8.58e-05	0.00283	CbGpPWpGaD
Clopidogrel—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	8.46e-05	0.00279	CbGpPWpGaD
Clopidogrel—Constipation—Mycophenolate mofetil—psoriasis	8.36e-05	0.000352	CcSEcCtD
Clopidogrel—Pain—Mycophenolate mofetil—psoriasis	8.36e-05	0.000352	CcSEcCtD
Clopidogrel—Infection—Triamcinolone—psoriasis	8.33e-05	0.000351	CcSEcCtD
Clopidogrel—Hypotension—Hydrocortisone—psoriasis	8.32e-05	0.00035	CcSEcCtD
Clopidogrel—Haematuria—Methotrexate—psoriasis	8.28e-05	0.000349	CcSEcCtD
Clopidogrel—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.27e-05	0.00273	CbGpPWpGaD
Clopidogrel—Feeling abnormal—Cyclosporine—psoriasis	8.25e-05	0.000348	CcSEcCtD
Clopidogrel—Shock—Triamcinolone—psoriasis	8.25e-05	0.000347	CcSEcCtD
Clopidogrel—Insomnia—Prednisolone—psoriasis	8.24e-05	0.000347	CcSEcCtD
Clopidogrel—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	8.23e-05	0.00271	CbGpPWpGaD
Clopidogrel—Hepatobiliary disease—Methotrexate—psoriasis	8.21e-05	0.000346	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Cyclosporine—psoriasis	8.19e-05	0.000345	CcSEcCtD
Clopidogrel—Loss of consciousness—Betamethasone—psoriasis	8.19e-05	0.000345	CcSEcCtD
Clopidogrel—Loss of consciousness—Dexamethasone—psoriasis	8.19e-05	0.000345	CcSEcCtD
Clopidogrel—Dizziness—Mycophenolic acid—psoriasis	8.19e-05	0.000345	CcSEcCtD
Clopidogrel—Epistaxis—Methotrexate—psoriasis	8.19e-05	0.000345	CcSEcCtD
Clopidogrel—Paraesthesia—Prednisolone—psoriasis	8.18e-05	0.000345	CcSEcCtD
Clopidogrel—Mental disorder—Prednisone—psoriasis	8.17e-05	0.000344	CcSEcCtD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	8.14e-05	0.00268	CbGpPWpGaD
Clopidogrel—Malnutrition—Prednisone—psoriasis	8.12e-05	0.000342	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Hydrocortisone—psoriasis	8.11e-05	0.000342	CcSEcCtD
Clopidogrel—Agranulocytosis—Methotrexate—psoriasis	8.1e-05	0.000341	CcSEcCtD
Clopidogrel—Feeling abnormal—Mycophenolate mofetil—psoriasis	8.05e-05	0.000339	CcSEcCtD
Clopidogrel—Insomnia—Hydrocortisone—psoriasis	8.05e-05	0.000339	CcSEcCtD
Clopidogrel—Hypertension—Dexamethasone—psoriasis	8.05e-05	0.000339	CcSEcCtD
Clopidogrel—Hypertension—Betamethasone—psoriasis	8.05e-05	0.000339	CcSEcCtD
Clopidogrel—Paraesthesia—Hydrocortisone—psoriasis	7.99e-05	0.000337	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	7.99e-05	0.000337	CcSEcCtD
Clopidogrel—Urticaria—Cyclosporine—psoriasis	7.96e-05	0.000335	CcSEcCtD
Clopidogrel—Myalgia—Dexamethasone—psoriasis	7.93e-05	0.000334	CcSEcCtD
Clopidogrel—Myalgia—Betamethasone—psoriasis	7.93e-05	0.000334	CcSEcCtD
Clopidogrel—Body temperature increased—Cyclosporine—psoriasis	7.92e-05	0.000334	CcSEcCtD
Clopidogrel—Abdominal pain—Cyclosporine—psoriasis	7.92e-05	0.000334	CcSEcCtD
Clopidogrel—Anxiety—Betamethasone—psoriasis	7.91e-05	0.000333	CcSEcCtD
Clopidogrel—Anxiety—Dexamethasone—psoriasis	7.91e-05	0.000333	CcSEcCtD
Clopidogrel—Vomiting—Mycophenolic acid—psoriasis	7.87e-05	0.000332	CcSEcCtD
Clopidogrel—Dyspepsia—Hydrocortisone—psoriasis	7.84e-05	0.00033	CcSEcCtD
Clopidogrel—Haemoglobin—Methotrexate—psoriasis	7.83e-05	0.00033	CcSEcCtD
Clopidogrel—Rash—Mycophenolic acid—psoriasis	7.81e-05	0.000329	CcSEcCtD
Clopidogrel—Dermatitis—Mycophenolic acid—psoriasis	7.8e-05	0.000329	CcSEcCtD
Clopidogrel—Pain—Prednisolone—psoriasis	7.79e-05	0.000328	CcSEcCtD
Clopidogrel—Haemorrhage—Methotrexate—psoriasis	7.79e-05	0.000328	CcSEcCtD
Clopidogrel—Hepatitis—Methotrexate—psoriasis	7.79e-05	0.000328	CcSEcCtD
Clopidogrel—Urticaria—Mycophenolate mofetil—psoriasis	7.76e-05	0.000327	CcSEcCtD
Clopidogrel—Headache—Mycophenolic acid—psoriasis	7.76e-05	0.000327	CcSEcCtD
Clopidogrel—P2RY12—G alpha (i) signalling events—CXCL8—psoriasis	7.74e-05	0.00255	CbGpPWpGaD
Clopidogrel—Abdominal pain—Mycophenolate mofetil—psoriasis	7.72e-05	0.000325	CcSEcCtD
Clopidogrel—Body temperature increased—Mycophenolate mofetil—psoriasis	7.72e-05	0.000325	CcSEcCtD
Clopidogrel—Urinary tract disorder—Methotrexate—psoriasis	7.69e-05	0.000324	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Hydrocortisone—psoriasis	7.69e-05	0.000324	CcSEcCtD
Clopidogrel—Fatigue—Hydrocortisone—psoriasis	7.68e-05	0.000323	CcSEcCtD
Clopidogrel—Urethral disorder—Methotrexate—psoriasis	7.64e-05	0.000322	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Triamcinolone—psoriasis	7.64e-05	0.000322	CcSEcCtD
Clopidogrel—Pain—Hydrocortisone—psoriasis	7.61e-05	0.000321	CcSEcCtD
Clopidogrel—Anaphylactic shock—Betamethasone—psoriasis	7.61e-05	0.00032	CcSEcCtD
Clopidogrel—Anaphylactic shock—Dexamethasone—psoriasis	7.61e-05	0.00032	CcSEcCtD
Clopidogrel—Oedema—Dexamethasone—psoriasis	7.61e-05	0.00032	CcSEcCtD
Clopidogrel—Oedema—Betamethasone—psoriasis	7.61e-05	0.00032	CcSEcCtD
Clopidogrel—Insomnia—Triamcinolone—psoriasis	7.58e-05	0.000319	CcSEcCtD
Clopidogrel—Infection—Dexamethasone—psoriasis	7.56e-05	0.000318	CcSEcCtD
Clopidogrel—Infection—Betamethasone—psoriasis	7.56e-05	0.000318	CcSEcCtD
Clopidogrel—Paraesthesia—Triamcinolone—psoriasis	7.53e-05	0.000317	CcSEcCtD
Clopidogrel—Feeling abnormal—Prednisolone—psoriasis	7.51e-05	0.000316	CcSEcCtD
Clopidogrel—Visual impairment—Methotrexate—psoriasis	7.51e-05	0.000316	CcSEcCtD
Clopidogrel—Anaemia—Prednisone—psoriasis	7.5e-05	0.000316	CcSEcCtD
Clopidogrel—Shock—Betamethasone—psoriasis	7.48e-05	0.000315	CcSEcCtD
Clopidogrel—Shock—Dexamethasone—psoriasis	7.48e-05	0.000315	CcSEcCtD
Clopidogrel—Dyspnoea—Triamcinolone—psoriasis	7.47e-05	0.000315	CcSEcCtD
Clopidogrel—Nervous system disorder—Betamethasone—psoriasis	7.46e-05	0.000314	CcSEcCtD
Clopidogrel—Nervous system disorder—Dexamethasone—psoriasis	7.46e-05	0.000314	CcSEcCtD
Clopidogrel—Angioedema—Prednisone—psoriasis	7.42e-05	0.000312	CcSEcCtD
Clopidogrel—CYP3A4—Tryptophan metabolism—CAT—psoriasis	7.4e-05	0.00244	CbGpPWpGaD
Clopidogrel—Hypersensitivity—Cyclosporine—psoriasis	7.38e-05	0.000311	CcSEcCtD
Clopidogrel—Dyspepsia—Triamcinolone—psoriasis	7.38e-05	0.000311	CcSEcCtD
Clopidogrel—Erythema multiforme—Methotrexate—psoriasis	7.37e-05	0.00031	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—IL10—psoriasis	7.36e-05	0.00243	CbGpPWpGaD
Clopidogrel—Nausea—Mycophenolic acid—psoriasis	7.35e-05	0.00031	CcSEcCtD
Clopidogrel—Feeling abnormal—Hydrocortisone—psoriasis	7.34e-05	0.000309	CcSEcCtD
Clopidogrel—Vertigo—Prednisone—psoriasis	7.29e-05	0.000307	CcSEcCtD
Clopidogrel—Eye disorder—Methotrexate—psoriasis	7.28e-05	0.000307	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Hydrocortisone—psoriasis	7.28e-05	0.000307	CcSEcCtD
Clopidogrel—Syncope—Prednisone—psoriasis	7.28e-05	0.000307	CcSEcCtD
Clopidogrel—Tinnitus—Methotrexate—psoriasis	7.26e-05	0.000306	CcSEcCtD
Clopidogrel—Urticaria—Prednisolone—psoriasis	7.24e-05	0.000305	CcSEcCtD
Clopidogrel—Fatigue—Triamcinolone—psoriasis	7.23e-05	0.000304	CcSEcCtD
Clopidogrel—Hypersensitivity—Mycophenolate mofetil—psoriasis	7.2e-05	0.000303	CcSEcCtD
Clopidogrel—Asthenia—Cyclosporine—psoriasis	7.19e-05	0.000303	CcSEcCtD
Clopidogrel—Pain—Triamcinolone—psoriasis	7.17e-05	0.000302	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—IL4—psoriasis	7.16e-05	0.00236	CbGpPWpGaD
Clopidogrel—Loss of consciousness—Prednisone—psoriasis	7.13e-05	0.000301	CcSEcCtD
Clopidogrel—Hypotension—Dexamethasone—psoriasis	7.11e-05	0.000299	CcSEcCtD
Clopidogrel—Hypotension—Betamethasone—psoriasis	7.11e-05	0.000299	CcSEcCtD
Clopidogrel—Pruritus—Cyclosporine—psoriasis	7.09e-05	0.000299	CcSEcCtD
Clopidogrel—Urticaria—Hydrocortisone—psoriasis	7.07e-05	0.000298	CcSEcCtD
Clopidogrel—Angiopathy—Methotrexate—psoriasis	7.07e-05	0.000298	CcSEcCtD
Clopidogrel—Immune system disorder—Methotrexate—psoriasis	7.04e-05	0.000297	CcSEcCtD
Clopidogrel—Abdominal pain—Hydrocortisone—psoriasis	7.04e-05	0.000296	CcSEcCtD
Clopidogrel—Body temperature increased—Hydrocortisone—psoriasis	7.04e-05	0.000296	CcSEcCtD
Clopidogrel—Mediastinal disorder—Methotrexate—psoriasis	7.02e-05	0.000296	CcSEcCtD
Clopidogrel—Asthenia—Mycophenolate mofetil—psoriasis	7.01e-05	0.000295	CcSEcCtD
Clopidogrel—Hypertension—Prednisone—psoriasis	7.01e-05	0.000295	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—HLA-B—psoriasis	7e-05	0.00231	CbGpPWpGaD
Clopidogrel—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	7e-05	0.00231	CbGpPWpGaD
Clopidogrel—Musculoskeletal discomfort—Dexamethasone—psoriasis	6.93e-05	0.000292	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Betamethasone—psoriasis	6.93e-05	0.000292	CcSEcCtD
Clopidogrel—Pruritus—Mycophenolate mofetil—psoriasis	6.91e-05	0.000291	CcSEcCtD
Clopidogrel—Myalgia—Prednisone—psoriasis	6.91e-05	0.000291	CcSEcCtD
Clopidogrel—Arthralgia—Prednisone—psoriasis	6.91e-05	0.000291	CcSEcCtD
Clopidogrel—Feeling abnormal—Triamcinolone—psoriasis	6.91e-05	0.000291	CcSEcCtD
Clopidogrel—Anxiety—Prednisone—psoriasis	6.89e-05	0.00029	CcSEcCtD
Clopidogrel—Insomnia—Dexamethasone—psoriasis	6.88e-05	0.00029	CcSEcCtD
Clopidogrel—Insomnia—Betamethasone—psoriasis	6.88e-05	0.00029	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	6.86e-05	0.000289	CcSEcCtD
Clopidogrel—Diarrhoea—Cyclosporine—psoriasis	6.85e-05	0.000289	CcSEcCtD
Clopidogrel—Paraesthesia—Betamethasone—psoriasis	6.83e-05	0.000288	CcSEcCtD
Clopidogrel—Paraesthesia—Dexamethasone—psoriasis	6.83e-05	0.000288	CcSEcCtD
Clopidogrel—Mental disorder—Methotrexate—psoriasis	6.83e-05	0.000288	CcSEcCtD
Clopidogrel—Malnutrition—Methotrexate—psoriasis	6.78e-05	0.000286	CcSEcCtD
Clopidogrel—Hypersensitivity—Prednisolone—psoriasis	6.72e-05	0.000283	CcSEcCtD
Clopidogrel—Dyspepsia—Dexamethasone—psoriasis	6.7e-05	0.000282	CcSEcCtD
Clopidogrel—Dyspepsia—Betamethasone—psoriasis	6.7e-05	0.000282	CcSEcCtD
Clopidogrel—Diarrhoea—Mycophenolate mofetil—psoriasis	6.69e-05	0.000282	CcSEcCtD
Clopidogrel—Urticaria—Triamcinolone—psoriasis	6.66e-05	0.000281	CcSEcCtD
Clopidogrel—Body temperature increased—Triamcinolone—psoriasis	6.63e-05	0.000279	CcSEcCtD
Clopidogrel—Dizziness—Cyclosporine—psoriasis	6.62e-05	0.000279	CcSEcCtD
Clopidogrel—Anaphylactic shock—Prednisone—psoriasis	6.62e-05	0.000279	CcSEcCtD
Clopidogrel—Oedema—Prednisone—psoriasis	6.62e-05	0.000279	CcSEcCtD
Clopidogrel—P2RY12—Platelet activation, signaling and aggregation—VEGFA—psoriasis	6.6e-05	0.00218	CbGpPWpGaD
Clopidogrel—Infection—Prednisone—psoriasis	6.58e-05	0.000277	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Dexamethasone—psoriasis	6.57e-05	0.000277	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Betamethasone—psoriasis	6.57e-05	0.000277	CcSEcCtD
Clopidogrel—Back pain—Methotrexate—psoriasis	6.56e-05	0.000276	CcSEcCtD
Clopidogrel—Hypersensitivity—Hydrocortisone—psoriasis	6.56e-05	0.000276	CcSEcCtD
Clopidogrel—Fatigue—Betamethasone—psoriasis	6.56e-05	0.000276	CcSEcCtD
Clopidogrel—Fatigue—Dexamethasone—psoriasis	6.56e-05	0.000276	CcSEcCtD
Clopidogrel—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	6.52e-05	0.00215	CbGpPWpGaD
Clopidogrel—Shock—Prednisone—psoriasis	6.52e-05	0.000275	CcSEcCtD
Clopidogrel—Pain—Dexamethasone—psoriasis	6.5e-05	0.000274	CcSEcCtD
Clopidogrel—Pain—Betamethasone—psoriasis	6.5e-05	0.000274	CcSEcCtD
Clopidogrel—Nervous system disorder—Prednisone—psoriasis	6.5e-05	0.000274	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—HLA-A—psoriasis	6.49e-05	0.00214	CbGpPWpGaD
Clopidogrel—Dizziness—Mycophenolate mofetil—psoriasis	6.46e-05	0.000272	CcSEcCtD
Clopidogrel—Skin disorder—Prednisone—psoriasis	6.43e-05	0.000271	CcSEcCtD
Clopidogrel—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	6.41e-05	0.00211	CbGpPWpGaD
Clopidogrel—Asthenia—Hydrocortisone—psoriasis	6.39e-05	0.000269	CcSEcCtD
Clopidogrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.38e-05	0.0021	CbGpPWpGaD
Clopidogrel—Vomiting—Cyclosporine—psoriasis	6.37e-05	0.000268	CcSEcCtD
Clopidogrel—Rash—Cyclosporine—psoriasis	6.32e-05	0.000266	CcSEcCtD
Clopidogrel—Dermatitis—Cyclosporine—psoriasis	6.31e-05	0.000266	CcSEcCtD
Clopidogrel—Pruritus—Hydrocortisone—psoriasis	6.3e-05	0.000265	CcSEcCtD
Clopidogrel—Headache—Cyclosporine—psoriasis	6.28e-05	0.000264	CcSEcCtD
Clopidogrel—Anaemia—Methotrexate—psoriasis	6.27e-05	0.000264	CcSEcCtD
Clopidogrel—Feeling abnormal—Dexamethasone—psoriasis	6.27e-05	0.000264	CcSEcCtD
Clopidogrel—Feeling abnormal—Betamethasone—psoriasis	6.27e-05	0.000264	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Betamethasone—psoriasis	6.22e-05	0.000262	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Dexamethasone—psoriasis	6.22e-05	0.000262	CcSEcCtD
Clopidogrel—Vomiting—Mycophenolate mofetil—psoriasis	6.21e-05	0.000262	CcSEcCtD
Clopidogrel—Hypersensitivity—Triamcinolone—psoriasis	6.18e-05	0.00026	CcSEcCtD
Clopidogrel—Rash—Mycophenolate mofetil—psoriasis	6.16e-05	0.00026	CcSEcCtD
Clopidogrel—Dermatitis—Mycophenolate mofetil—psoriasis	6.16e-05	0.000259	CcSEcCtD
Clopidogrel—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	6.15e-05	0.00203	CbGpPWpGaD
Clopidogrel—Headache—Mycophenolate mofetil—psoriasis	6.12e-05	0.000258	CcSEcCtD
Clopidogrel—Vertigo—Methotrexate—psoriasis	6.09e-05	0.000257	CcSEcCtD
Clopidogrel—Diarrhoea—Hydrocortisone—psoriasis	6.09e-05	0.000257	CcSEcCtD
Clopidogrel—Leukopenia—Methotrexate—psoriasis	6.07e-05	0.000256	CcSEcCtD
Clopidogrel—Urticaria—Dexamethasone—psoriasis	6.04e-05	0.000255	CcSEcCtD
Clopidogrel—Urticaria—Betamethasone—psoriasis	6.04e-05	0.000255	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Prednisone—psoriasis	6.03e-05	0.000254	CcSEcCtD
Clopidogrel—Dizziness—Prednisolone—psoriasis	6.03e-05	0.000254	CcSEcCtD
Clopidogrel—Asthenia—Triamcinolone—psoriasis	6.01e-05	0.000253	CcSEcCtD
Clopidogrel—Body temperature increased—Dexamethasone—psoriasis	6.01e-05	0.000253	CcSEcCtD
Clopidogrel—Abdominal pain—Betamethasone—psoriasis	6.01e-05	0.000253	CcSEcCtD
Clopidogrel—Abdominal pain—Dexamethasone—psoriasis	6.01e-05	0.000253	CcSEcCtD
Clopidogrel—Body temperature increased—Betamethasone—psoriasis	6.01e-05	0.000253	CcSEcCtD
Clopidogrel—Insomnia—Prednisone—psoriasis	5.99e-05	0.000252	CcSEcCtD
Clopidogrel—Nausea—Cyclosporine—psoriasis	5.95e-05	0.000251	CcSEcCtD
Clopidogrel—Paraesthesia—Prednisone—psoriasis	5.95e-05	0.000251	CcSEcCtD
Clopidogrel—Pruritus—Triamcinolone—psoriasis	5.93e-05	0.00025	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5.93e-05	0.00195	CbGpPWpGaD
Clopidogrel—Cough—Methotrexate—psoriasis	5.92e-05	0.000249	CcSEcCtD
Clopidogrel—Dizziness—Hydrocortisone—psoriasis	5.89e-05	0.000248	CcSEcCtD
Clopidogrel—P2RY12—Hemostasis—NOS2—psoriasis	5.88e-05	0.00194	CbGpPWpGaD
Clopidogrel—Dyspepsia—Prednisone—psoriasis	5.83e-05	0.000246	CcSEcCtD
Clopidogrel—Nausea—Mycophenolate mofetil—psoriasis	5.8e-05	0.000245	CcSEcCtD
Clopidogrel—Myalgia—Methotrexate—psoriasis	5.77e-05	0.000243	CcSEcCtD
Clopidogrel—Arthralgia—Methotrexate—psoriasis	5.77e-05	0.000243	CcSEcCtD
Clopidogrel—Chest pain—Methotrexate—psoriasis	5.77e-05	0.000243	CcSEcCtD
Clopidogrel—Rash—Prednisolone—psoriasis	5.75e-05	0.000242	CcSEcCtD
Clopidogrel—Dermatitis—Prednisolone—psoriasis	5.74e-05	0.000242	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	5.73e-05	0.000242	CcSEcCtD
Clopidogrel—Fatigue—Prednisone—psoriasis	5.71e-05	0.000241	CcSEcCtD
Clopidogrel—Headache—Prednisolone—psoriasis	5.71e-05	0.000241	CcSEcCtD
Clopidogrel—Constipation—Prednisone—psoriasis	5.66e-05	0.000239	CcSEcCtD
Clopidogrel—Vomiting—Hydrocortisone—psoriasis	5.66e-05	0.000238	CcSEcCtD
Clopidogrel—Rash—Hydrocortisone—psoriasis	5.61e-05	0.000236	CcSEcCtD
Clopidogrel—Dermatitis—Hydrocortisone—psoriasis	5.61e-05	0.000236	CcSEcCtD
Clopidogrel—Confusional state—Methotrexate—psoriasis	5.58e-05	0.000235	CcSEcCtD
Clopidogrel—Headache—Hydrocortisone—psoriasis	5.58e-05	0.000235	CcSEcCtD
Clopidogrel—Dizziness—Triamcinolone—psoriasis	5.54e-05	0.000234	CcSEcCtD
Clopidogrel—Anaphylactic shock—Methotrexate—psoriasis	5.54e-05	0.000233	CcSEcCtD
Clopidogrel—Infection—Methotrexate—psoriasis	5.5e-05	0.000232	CcSEcCtD
Clopidogrel—Feeling abnormal—Prednisone—psoriasis	5.46e-05	0.00023	CcSEcCtD
Clopidogrel—Asthenia—Dexamethasone—psoriasis	5.46e-05	0.00023	CcSEcCtD
Clopidogrel—Asthenia—Betamethasone—psoriasis	5.46e-05	0.00023	CcSEcCtD
Clopidogrel—Nervous system disorder—Methotrexate—psoriasis	5.43e-05	0.000229	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Prednisone—psoriasis	5.42e-05	0.000228	CcSEcCtD
Clopidogrel—Nausea—Prednisolone—psoriasis	5.41e-05	0.000228	CcSEcCtD
Clopidogrel—Pruritus—Dexamethasone—psoriasis	5.38e-05	0.000227	CcSEcCtD
Clopidogrel—Pruritus—Betamethasone—psoriasis	5.38e-05	0.000227	CcSEcCtD
Clopidogrel—Skin disorder—Methotrexate—psoriasis	5.38e-05	0.000227	CcSEcCtD
Clopidogrel—Vomiting—Triamcinolone—psoriasis	5.33e-05	0.000225	CcSEcCtD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	5.33e-05	0.00176	CbGpPWpGaD
Clopidogrel—Nausea—Hydrocortisone—psoriasis	5.29e-05	0.000223	CcSEcCtD
Clopidogrel—Rash—Triamcinolone—psoriasis	5.29e-05	0.000223	CcSEcCtD
Clopidogrel—Dermatitis—Triamcinolone—psoriasis	5.28e-05	0.000222	CcSEcCtD
Clopidogrel—Urticaria—Prednisone—psoriasis	5.26e-05	0.000222	CcSEcCtD
Clopidogrel—P2RY12—Signaling Pathways—CCL20—psoriasis	5.26e-05	0.00173	CbGpPWpGaD
Clopidogrel—Headache—Triamcinolone—psoriasis	5.25e-05	0.000221	CcSEcCtD
Clopidogrel—Abdominal pain—Prednisone—psoriasis	5.24e-05	0.000221	CcSEcCtD
Clopidogrel—Body temperature increased—Prednisone—psoriasis	5.24e-05	0.000221	CcSEcCtD
Clopidogrel—Diarrhoea—Dexamethasone—psoriasis	5.2e-05	0.000219	CcSEcCtD
Clopidogrel—Diarrhoea—Betamethasone—psoriasis	5.2e-05	0.000219	CcSEcCtD
Clopidogrel—Hypotension—Methotrexate—psoriasis	5.17e-05	0.000218	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Methotrexate—psoriasis	5.04e-05	0.000212	CcSEcCtD
Clopidogrel—Dizziness—Betamethasone—psoriasis	5.03e-05	0.000212	CcSEcCtD
Clopidogrel—Dizziness—Dexamethasone—psoriasis	5.03e-05	0.000212	CcSEcCtD
Clopidogrel—Insomnia—Methotrexate—psoriasis	5.01e-05	0.000211	CcSEcCtD
Clopidogrel—Nausea—Triamcinolone—psoriasis	4.98e-05	0.00021	CcSEcCtD
Clopidogrel—Paraesthesia—Methotrexate—psoriasis	4.97e-05	0.000209	CcSEcCtD
Clopidogrel—Dyspnoea—Methotrexate—psoriasis	4.94e-05	0.000208	CcSEcCtD
Clopidogrel—Hypersensitivity—Prednisone—psoriasis	4.88e-05	0.000206	CcSEcCtD
Clopidogrel—Dyspepsia—Methotrexate—psoriasis	4.87e-05	0.000205	CcSEcCtD
Clopidogrel—Vomiting—Betamethasone—psoriasis	4.84e-05	0.000204	CcSEcCtD
Clopidogrel—Vomiting—Dexamethasone—psoriasis	4.84e-05	0.000204	CcSEcCtD
Clopidogrel—Rash—Betamethasone—psoriasis	4.8e-05	0.000202	CcSEcCtD
Clopidogrel—Rash—Dexamethasone—psoriasis	4.8e-05	0.000202	CcSEcCtD
Clopidogrel—Dermatitis—Dexamethasone—psoriasis	4.79e-05	0.000202	CcSEcCtD
Clopidogrel—Dermatitis—Betamethasone—psoriasis	4.79e-05	0.000202	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Methotrexate—psoriasis	4.78e-05	0.000201	CcSEcCtD
Clopidogrel—Fatigue—Methotrexate—psoriasis	4.77e-05	0.000201	CcSEcCtD
Clopidogrel—Headache—Dexamethasone—psoriasis	4.76e-05	0.000201	CcSEcCtD
Clopidogrel—Headache—Betamethasone—psoriasis	4.76e-05	0.000201	CcSEcCtD
Clopidogrel—Asthenia—Prednisone—psoriasis	4.75e-05	0.0002	CcSEcCtD
Clopidogrel—Pain—Methotrexate—psoriasis	4.73e-05	0.000199	CcSEcCtD
Clopidogrel—Pruritus—Prednisone—psoriasis	4.69e-05	0.000197	CcSEcCtD
Clopidogrel—P2RY12—GPCR ligand binding—CXCL8—psoriasis	4.69e-05	0.00154	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	4.61e-05	0.00152	CbGpPWpGaD
Clopidogrel—Feeling abnormal—Methotrexate—psoriasis	4.56e-05	0.000192	CcSEcCtD
Clopidogrel—Diarrhoea—Prednisone—psoriasis	4.53e-05	0.000191	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Methotrexate—psoriasis	4.53e-05	0.000191	CcSEcCtD
Clopidogrel—Nausea—Dexamethasone—psoriasis	4.52e-05	0.00019	CcSEcCtD
Clopidogrel—Nausea—Betamethasone—psoriasis	4.52e-05	0.00019	CcSEcCtD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	4.43e-05	0.00146	CbGpPWpGaD
Clopidogrel—Urticaria—Methotrexate—psoriasis	4.4e-05	0.000185	CcSEcCtD
Clopidogrel—Dizziness—Prednisone—psoriasis	4.38e-05	0.000185	CcSEcCtD
Clopidogrel—Abdominal pain—Methotrexate—psoriasis	4.38e-05	0.000184	CcSEcCtD
Clopidogrel—Body temperature increased—Methotrexate—psoriasis	4.38e-05	0.000184	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—IFNG—psoriasis	4.33e-05	0.00143	CbGpPWpGaD
Clopidogrel—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	4.32e-05	0.00142	CbGpPWpGaD
Clopidogrel—Vomiting—Prednisone—psoriasis	4.21e-05	0.000177	CcSEcCtD
Clopidogrel—Rash—Prednisone—psoriasis	4.18e-05	0.000176	CcSEcCtD
Clopidogrel—Dermatitis—Prednisone—psoriasis	4.17e-05	0.000176	CcSEcCtD
Clopidogrel—Headache—Prednisone—psoriasis	4.15e-05	0.000175	CcSEcCtD
Clopidogrel—Hypersensitivity—Methotrexate—psoriasis	4.08e-05	0.000172	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—CXCL8—psoriasis	4.03e-05	0.00133	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	4.02e-05	0.00133	CbGpPWpGaD
Clopidogrel—Asthenia—Methotrexate—psoriasis	3.97e-05	0.000167	CcSEcCtD
Clopidogrel—Nausea—Prednisone—psoriasis	3.93e-05	0.000166	CcSEcCtD
Clopidogrel—Pruritus—Methotrexate—psoriasis	3.92e-05	0.000165	CcSEcCtD
Clopidogrel—CYP2B6—Metabolism—NDUFA5—psoriasis	3.8e-05	0.00125	CbGpPWpGaD
Clopidogrel—Diarrhoea—Methotrexate—psoriasis	3.79e-05	0.00016	CcSEcCtD
Clopidogrel—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.78e-05	0.00124	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—NDUFA5—psoriasis	3.71e-05	0.00122	CbGpPWpGaD
Clopidogrel—Dizziness—Methotrexate—psoriasis	3.66e-05	0.000154	CcSEcCtD
Clopidogrel—Vomiting—Methotrexate—psoriasis	3.52e-05	0.000148	CcSEcCtD
Clopidogrel—Rash—Methotrexate—psoriasis	3.49e-05	0.000147	CcSEcCtD
Clopidogrel—Dermatitis—Methotrexate—psoriasis	3.49e-05	0.000147	CcSEcCtD
Clopidogrel—Headache—Methotrexate—psoriasis	3.47e-05	0.000146	CcSEcCtD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	3.45e-05	0.00114	CbGpPWpGaD
Clopidogrel—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	3.45e-05	0.00114	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—VEGFA—psoriasis	3.4e-05	0.00112	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.32e-05	0.00109	CbGpPWpGaD
Clopidogrel—Nausea—Methotrexate—psoriasis	3.29e-05	0.000139	CcSEcCtD
Clopidogrel—ABCB1—Allograft Rejection—VEGFA—psoriasis	3.27e-05	0.00108	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CYP2S1—psoriasis	3.23e-05	0.00106	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—NDUFA5—psoriasis	3.22e-05	0.00106	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CYP2S1—psoriasis	3.16e-05	0.00104	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3e-05	0.000988	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—SOCS1—psoriasis	2.9e-05	0.000955	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—NDUFA5—psoriasis	2.87e-05	0.000946	CbGpPWpGaD
Clopidogrel—ABCB1—Allograft Rejection—TNF—psoriasis	2.8e-05	0.000924	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—NDUFA5—psoriasis	2.8e-05	0.000923	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.79e-05	0.000918	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—TYK2—psoriasis	2.76e-05	0.00091	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CYP2S1—psoriasis	2.73e-05	0.000901	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.68e-05	0.000882	CbGpPWpGaD
Clopidogrel—P2RY12—GPCR downstream signaling—CXCL8—psoriasis	2.65e-05	0.000873	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—NDUFA5—psoriasis	2.62e-05	0.000863	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.6e-05	0.000858	CbGpPWpGaD
Clopidogrel—P2RY12—Hemostasis—TP53—psoriasis	2.57e-05	0.000848	CbGpPWpGaD
Clopidogrel—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.48e-05	0.000819	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CYP2S1—psoriasis	2.44e-05	0.000804	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.44e-05	0.000804	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—CXCL8—psoriasis	2.4e-05	0.000793	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CYP2S1—psoriasis	2.38e-05	0.000785	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—NDUFA5—psoriasis	2.24e-05	0.000737	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CYP2S1—psoriasis	2.23e-05	0.000734	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—LEP—psoriasis	2.14e-05	0.000705	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—APOE—psoriasis	2.14e-05	0.000705	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.09e-05	0.000687	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—NFKBIA—psoriasis	1.99e-05	0.000657	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CYP2S1—psoriasis	1.9e-05	0.000627	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.85e-05	0.000609	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.78e-05	0.000586	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—NDUFA5—psoriasis	1.73e-05	0.000569	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TYK2—psoriasis	1.63e-05	0.000538	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.61e-05	0.000532	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CARM1—psoriasis	1.58e-05	0.00052	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CARM1—psoriasis	1.54e-05	0.000508	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CYP2S1—psoriasis	1.47e-05	0.000484	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.43e-05	0.000472	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—CXCL8—psoriasis	1.42e-05	0.000468	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.38e-05	0.000456	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling by GPCR—IL6—psoriasis	1.35e-05	0.000445	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CARM1—psoriasis	1.34e-05	0.00044	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—JUN—psoriasis	1.32e-05	0.000435	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.28e-05	0.000422	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—NFKB1—psoriasis	1.27e-05	0.000419	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.25e-05	0.000411	CbGpPWpGaD
Clopidogrel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.22e-05	0.000402	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CARM1—psoriasis	1.19e-05	0.000393	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.17e-05	0.000384	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CARM1—psoriasis	1.16e-05	0.000383	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—VEGFA—psoriasis	1.15e-05	0.00038	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—STAT3—psoriasis	1.14e-05	0.000377	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.11e-05	0.000367	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CARM1—psoriasis	1.09e-05	0.000358	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.02e-05	0.000335	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.97e-06	0.000329	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—CAT—psoriasis	9.7e-06	0.00032	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—CAT—psoriasis	9.48e-06	0.000313	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CARM1—psoriasis	9.29e-06	0.000306	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—TP53—psoriasis	8.72e-06	0.000287	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.68e-06	0.000286	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—CAT—psoriasis	8.21e-06	0.000271	CbGpPWpGaD
Clopidogrel—P2RY12—Signaling Pathways—IL6—psoriasis	7.98e-06	0.000263	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—APOE—psoriasis	7.54e-06	0.000248	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—APOE—psoriasis	7.37e-06	0.000243	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—CAT—psoriasis	7.33e-06	0.000242	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CARM1—psoriasis	7.17e-06	0.000236	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—CAT—psoriasis	7.16e-06	0.000236	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—CAT—psoriasis	6.68e-06	0.00022	CbGpPWpGaD
Clopidogrel—CYP2B6—Metabolism—PPARG—psoriasis	6.57e-06	0.000216	CbGpPWpGaD
Clopidogrel—CYP3A5—Metabolism—PPARG—psoriasis	6.42e-06	0.000212	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—APOE—psoriasis	6.38e-06	0.00021	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—CAT—psoriasis	5.71e-06	0.000188	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—APOE—psoriasis	5.7e-06	0.000188	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—APOE—psoriasis	5.56e-06	0.000183	CbGpPWpGaD
Clopidogrel—CYP2C8—Metabolism—PPARG—psoriasis	5.56e-06	0.000183	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—APOE—psoriasis	5.19e-06	0.000171	CbGpPWpGaD
Clopidogrel—CYP2C19—Metabolism—PPARG—psoriasis	4.96e-06	0.000164	CbGpPWpGaD
Clopidogrel—ABCB1—Metabolism—PPARG—psoriasis	4.84e-06	0.00016	CbGpPWpGaD
Clopidogrel—CYP2C9—Metabolism—PPARG—psoriasis	4.52e-06	0.000149	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—APOE—psoriasis	4.44e-06	0.000146	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—CAT—psoriasis	4.41e-06	0.000145	CbGpPWpGaD
Clopidogrel—CYP1A2—Metabolism—PPARG—psoriasis	3.87e-06	0.000127	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—APOE—psoriasis	3.43e-06	0.000113	CbGpPWpGaD
Clopidogrel—CYP3A4—Metabolism—PPARG—psoriasis	2.98e-06	9.83e-05	CbGpPWpGaD
